You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radiopharmaceutical

Showing 1 - 25 of 469
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

Not yet recruiting
  • Cancer
  • +3 more
  • 177Lu-PSMA-I&T - escalating renal absorbed dose
  • 177Lu-PSMA-I&T - recommended phase 2 regime
  • (no location specified)
Jun 14, 2023

Recurrent Thyroid Cancer Trial in Baltimore (Combination treatment (CXRPT) of external beam radiation (XRT) plus radioactive

Recruiting
  • Recurrent Thyroid Cancer
  • Combination treatment (CXRPT) of external beam radiation (XRT) plus radioactive iodine (RAI)
  • Baltimore, Maryland
    The Johns Hopkins SKCCC
May 25, 2022

Alzheimer Trial in Canada, United States (18F-Flortaucipir radiopharmaceutical, 18F-MK-6240 radiopharmaceutical, Amyloid-ß

Recruiting
  • Alzheimer Disease
  • 18F-Flortaucipir radiopharmaceutical
  • +2 more
  • Berkeley, California
  • +7 more
Jan 23, 2023

Prostate Cancer, 18F- Fluorocholine, PSMA PET Trial (Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine)

Not yet recruiting
  • Prostate Cancer
  • +5 more
  • Radiopharmaceutical 18F-JK-PSMA-7
  • Radiopharmaceutical 18F-Fluorocholine
  • (no location specified)
Nov 17, 2022

Cancer of Unknown Primary Site Trial in Bendigo, Melbourne, Warrnambool (68Ga-FAPi-46, PET/CT imaging)

Not yet recruiting
  • Cancer of Unknown Primary Site
  • Bendigo, Victoria, Australia
  • +2 more
Feb 28, 2022

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

Prostate Cancer, Prostatic Tumor, Prostatic Disease Trial in Vancouver ([68Ga]Ga-HTK03149 PET/CT)

Active, not recruiting
  • Prostate Cancer
  • +5 more
  • [68Ga]Ga-HTK03149 PET/CT
  • Vancouver, British Columbia, Canada
    BC Cancer
Dec 1, 2021

Testicular Germ Cell Tumor Trial in Saint-Petersburg (Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel

Recruiting
  • Testicular Germ Cell Tumor
  • Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel lymph node using indocyanine green dye with/without methylene blue dye.
  • Radiopharmaceutical administration (Technetium/methylene blue)
  • Saint-Petersburg, Russian Federation
    Federal State Budgetary Institute N.N. Petrov National Medical R
Nov 10, 2023

Neuroblastoma Trial in Montréal, Sherbrooke (Radiopharmaceutical 68Ga-DOTATATE)

Recruiting
  • Neuroblastoma
  • Radiopharmaceutical 68Ga-DOTATATE
  • Montréal, Quebec, Canada
  • +2 more
Jan 3, 2023

Prostate Cancer Trial (Radiopharmaceutical 68Ga-PSMA-11 PET/CT)

Not yet recruiting
  • Prostate Cancer
  • Radiopharmaceutical 68Ga-PSMA-11 PET/CT
  • (no location specified)
Oct 12, 2022

Multiple Sclerosis Trial in Ladera Ranch (Entire-body PET-CT scans, Amyvid radiopharmaceutical)

Recruiting
  • Multiple Sclerosis
  • Entire-body PET-CT scans
  • Amyvid radiopharmaceutical
  • Ladera Ranch, California
    Brain Health Alliance
Mar 31, 2022

Neuroendocrine Carcinoma Trial in London (Lu-DOTA-TATE)

Active, not recruiting
  • Neuroendocrine Carcinoma
  • Lu-DOTA-TATE
  • London, Ontario, Canada
    London Health Sciences Centre
Apr 5, 2022

Metastatic Breast Cancer Trial in Dijon (18F Fluoroestradiol Radiopharmaceutical with PET/CT)

Recruiting
  • Metastatic Breast Cancer
  • 18F Fluoroestradiol Radiopharmaceutical with PET/CT
  • Dijon, France
    CGFL
Aug 2, 2022

FES F18 PET/CT in Metastatic Breast Cancer Patients

Recruiting
  • Metastatic Breast Cancer
  • 18F Fluoroestradiol Radiopharmaceutical with PET/CT
  • Long Beach, California
  • +5 more
Jan 19, 2023

Upper Digestive Tract Cancer Trial in Sherbrooke (Radiopharmaceutical 68Ga-PSMA)

Recruiting
  • Upper Digestive Tract Cancer
  • Radiopharmaceutical 68Ga-PSMA
  • Sherbrooke, Quebec, Canada
    CIUSSS de l'Estrie- CHUS Hospital
Jan 17, 2022

Exploration of Cluster Headache in a PET-MRI Study

Not yet recruiting
  • Cluster Headache, Episodic
  • PET-MRI in pain-free remission period
  • (no location specified)
Oct 18, 2021

Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)

Recruiting
  • Metastatic Hormone Naive Prostate Cancer
  • Sydney, New South Wales, Australia
  • +4 more
Nov 4, 2022

Solid Tumors Trial in New York (PET Imaging with Ga-68 Labeled F(ab') 2- Trastuzumab)

Completed
  • Solid Tumors
  • PET Imaging with Ga-68 Labeled F(ab') 2- Trastuzumab
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 23, 2020

Prostate Cancer Trial in Long Beach, West Los Angeles, Hines (stereotactic ablative radiotherapy, Pluvicto, topical

Not yet recruiting
  • Prostate Cancer
  • stereotactic ablative radiotherapy
  • +2 more
  • Long Beach, California
  • +2 more
Oct 13, 2023

Rubidium-82 - An Alternative Radiopharmaceutical for Myocardial

Completed
  • Coronary Artery Disease
  • Myocardial perfusion imaging using Rb-82 PET or Tc-99m or Tl SPECT
  • Ottawa, Ontario, Canada
    University of Ottawa Heart Institute
Nov 20, 2019

PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in

Completed
  • Prostate Cancer
  • 18F DCFPyL- Radiopharmaceutical
  • Baltimore, Maryland
    Johns Hopkins University
May 5, 2020

Cardiovascular Diseases Trial in New York (18F-mFBG for intravenous administration)

Recruiting
  • Cardiovascular Diseases
  • 18F-mFBG for intravenous administration
  • New York, New York
    Mount Sinai Morningside
May 23, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11 GBq (30 mCi) of 177Lu-PSMA-EB-01, 1.85 GBq (50 mCi) of

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • 1.11 GBq (30 mCi) of 177Lu-PSMA-EB-01
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 6, 2022

Latent Cancer Prostate Trial in Taoyuan City (Ga-68 PSMA ligand)

Completed
  • Latent Cancer Prostate
  • Ga-68 PSMA ligand
  • Taoyuan City, Taiwan
    Chang Gung Memorial Hospital ,Linkou
Jul 15, 2019

Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Radionuclide Therapy
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Jun 5, 2023